(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001
Synoptical table of idiopathic interstital pneumonia (IIP) findings in computed tomography (CT) – A practical tool and systematic review Source: International Congress 2014 – ILDs 5 Year: 2014
False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014
Incidental findings in Positron Emission Tomography - Computed Tomography for Lung Cancer Assessment Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging:comparative methodology in COPD patients Source: International Congress 2014 – COPD and PAH related imaging Year: 2014
Positron emission tomography (PET) using 18 F-fluorodeoxyglucose (18 FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007
Evaluation of thoracic HRCT findings in sarcoidosis Source: International Congress 2014 – Different modalities and techniques for lung imaging Year: 2014
Pulmonary glucose uptake measured by positron emission tomography in pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015
Density gradient of the lung parenchyma at computed tomography in patients with pulmonary hypertension Source: International Congress 2014 – ILDs 3 Year: 2014
18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
18F-Fluorodeoxyglucose (18FDG) PET pulmonary imaging: Role in detecting vascular inflammation Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002
Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008
Positron emission tomography in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005